Company Valuation: AsiaMedic Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 22.39 17.91 13.43 15.01 12.7 19.2
Change - -20% -25% 11.72% -15.38% 51.2%
Enterprise Value (EV) 1 18.29 13.89 12.13 14.86 22.37 27.38
Change - -24.04% -12.68% 22.48% 50.6% 22.38%
P/E -5.09x 26.7x 6.15x 7.67x 12.7x 9.72x
PBR 2.79x 2.05x 1.23x 1.13x 0.89x 1.2x
PEG - -0x 0x -0.6x -0.3x 0x
Capitalization / Revenue 1.46x 0.97x 0.71x 0.63x 0.44x 0.54x
EV / Revenue 1.19x 0.75x 0.64x 0.63x 0.77x 0.78x
EV / EBITDA -19.4x 11.9x 10.2x 9.28x 16.7x 17.6x
EV / EBIT -8.53x 17.5x 13.1x 20.6x 34.7x 41.1x
EV / FCF 14.6x 7.51x -31.8x 16.1x 21.5x -14.3x
FCF Yield 6.87% 13.3% -3.14% 6.2% 4.66% -6.99%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.003927 0.000599 0.001952 0.001696 0.000869 0.001749
Distribution rate - - - - - -
Net sales 1 15.38 18.42 19.04 23.75 29.09 35.29
EBITDA 1 -0.9441 1.17 1.189 1.6 1.336 1.56
EBIT 1 -2.144 0.7946 0.924 0.7197 0.6453 0.6667
Net income 1 -4.295 0.715 2.186 1.921 1.01 2.024
Net Debt 1 -4.105 -4.023 -1.305 -0.1524 9.675 8.18
Reference price 2 0.0200 0.0160 0.0120 0.0130 0.0110 0.0170
Nbr of stocks (in thousands) 1,119,522 1,119,522 1,119,522 1,154,522 1,154,522 1,129,522
Announcement Date 4/6/21 4/6/22 4/13/23 4/11/24 4/1/25 4/13/26
1SGD in Million2SGD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 17.18M
13.7x0.41x8.6x2.86% 119B
14.5x1.82x9.08x0.72% 92.92B
24.05x2.67x13.52x1.35% 26.97B
32.77x5.89x24.19x2.12% 22.17B
8.52x1.49x6.8x-.--% 22.61B
15.79x1.47x7.04x4.5% 14.47B
13.83x1x5.61x3.56% 12.42B
11.93x1.55x7.5x0.96% 11.08B
7.79x0.84x5.91x0.47% 10.45B
Average 15.88x 1.90x 9.81x 1.84% 33.21B
Weighted average by Cap. 15.53x 1.55x 9.75x 1.85%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 505 Stock
  4. Valuation AsiaMedic Limited